Just - Evotec Biologics
Jeremiah Genest is a seasoned quality professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as the Senior Director of Quality Technical and Risk at Just - Evotec Biologics, Jeremiah leads key quality initiatives ensuring compliance and inspection readiness for phase 3 manufacturing. Previously, positions held include Head of Quality Management Systems at Amylyx Pharmaceuticals, Senior Director at Vertex Pharmaceuticals, and roles at Thermo Fisher Scientific and Sanofi, where focus areas included quality management system implementation, risk management, and continuous improvement of quality systems. Early career experience at Millennium Pharmaceuticals involved managing various quality systems and leading significant projects to enhance quality operations across GxP regulations.
This person is not in any teams
This person is not in any offices
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com